Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease
J. Thomas Hutton(Hospital Clínico San Carlos), Jerry L. Morris, Bradley C. Hiner(Medical College of Wisconsin), Charles H. Adler(WinnMed), Cheryl Waters, Ronald F. Pfeiffer(Oregon Health & Science University), William C. Koller(Stanford University), A. Lieberman, Manfred D. Muenter, Robert L. Rodnitzky(University of Iowa), M. B. Stern(Duke University), H. I. Hurtig, J. Eric Ahlskog(Mayo Clinic), Rajesh Pahwa(University of Kansas Medical Center)
Cited by 89
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Variable expression of Parkinson's disease
|Neurology|1990|1.3k